Supplementary materials for the manuscript published in the Journal of Clinical Endocrinology and Metabolism: MPOWERED Trial Open-Label Extension: Long-Term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly Supplemental Table 1. Proportion of Patients With Active Acromegaly Symptoms, by Individual Symptom, by Visit During OLE Phase Supplemental Figure 1. Proportion of Patients With ≥1, 2, or 3 Active Acromegaly Symptoms by Visit During OLE Phase Supplemental Figure 2. Preferred Treatment Administration Method at End of OLE Phase